193 related articles for article (PubMed ID: 32730882)
1. YiQiFuMai Lyophilized Injection ameliorates tPA-induced hemorrhagic transformation by inhibiting cytoskeletal rearrangement associated with ROCK1 and NF-κB signaling pathways.
Pan XW; Wang MJ; Gong SS; Sun MH; Wang Y; Zhang YY; Li F; Yu BY; Kou JP
J Ethnopharmacol; 2020 Nov; 262():113161. PubMed ID: 32730882
[TBL] [Abstract][Full Text] [Related]
2. YiQiFuMai Powder Injection ameliorates the oxygen-glucose deprivation-induced brain microvascular endothelial barrier dysfunction associated with the NF-κB and ROCK1/MLC signaling pathways.
Cao GS; Chen HL; Zhang YY; Li F; Liu CH; Xiang X; Qi J; Chai CZ; Kou JP; Yu BY
J Ethnopharmacol; 2016 May; 183():18-28. PubMed ID: 26915982
[TBL] [Abstract][Full Text] [Related]
3. YiQiFuMai powder injection ameliorates blood-brain barrier dysfunction and brain edema after focal cerebral ischemia-reperfusion injury in mice.
Cao G; Ye X; Xu Y; Yin M; Chen H; Kou J; Yu B
Drug Des Devel Ther; 2016; 10():315-25. PubMed ID: 26834461
[TBL] [Abstract][Full Text] [Related]
4. YiQiFuMai Powder Injection attenuates coronary artery ligation-induced myocardial remodeling and heart failure through modulating MAPKs signaling pathway.
Pang LZ; Ju AC; Zheng XJ; Li F; Song YF; Zhao Y; Gu YF; Chen FL; Liu CH; Qi J; Gao Z; Kou JP; Yu BY
J Ethnopharmacol; 2017 Apr; 202():67-77. PubMed ID: 28237302
[TBL] [Abstract][Full Text] [Related]
5. Phthalide derivative CD21 attenuates tissue plasminogen activator-induced hemorrhagic transformation in ischemic stroke by enhancing macrophage scavenger receptor 1-mediated DAMP (peroxiredoxin 1) clearance.
Liu DL; Hong Z; Li JY; Yang YX; Chen C; Du JR
J Neuroinflammation; 2021 Jun; 18(1):143. PubMed ID: 34162400
[TBL] [Abstract][Full Text] [Related]
6. YiQiFuMai lyophilized injection attenuates cerebral ischemic injury with inhibition of neuronal autophagy through intervention in the NMMHC IIA-actin-ATG9A interaction.
Su L; Liu Y; Ma H; Zheng F; Daia Y; Wang T; Wang G; Li F; Zhang Y; Yu B; Gong S; Kou J
Phytomedicine; 2022 Jan; 95():153882. PubMed ID: 34968897
[TBL] [Abstract][Full Text] [Related]
7. YiQiFuMai Powder Injection Ameliorates Cerebral Ischemia by Inhibiting Endoplasmic Reticulum Stress-Mediated Neuronal Apoptosis.
Cao G; Zhou H; Jiang N; Han Y; Hu Y; Zhang Y; Qi J; Kou J; Yu B
Oxid Med Cell Longev; 2016; 2016():5493279. PubMed ID: 27087890
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke.
Liu H; Wang Y; Xiao Y; Hua Z; Cheng J; Jia J
Transl Stroke Res; 2016 Jun; 7(3):209-19. PubMed ID: 27018013
[TBL] [Abstract][Full Text] [Related]
9. YiQiFuMai lyophilized injection attenuates particulate matter-induced acute lung injury in mice via TLR4-mTOR-autophagy pathway.
Xia Y; S D; Jiang S; Fan R; Wang Y; Wang Y; Tang J; Zhang Y; He RL; Yu B; Kou J
Biomed Pharmacother; 2018 Dec; 108():906-913. PubMed ID: 30372902
[TBL] [Abstract][Full Text] [Related]
10. The role of connexin43 in hemorrhagic transformation after thrombolysis in vivo and in vitro.
Yang X; Chu H; Tang Y; Dong Q
Neuroscience; 2016 Aug; 329():54-65. PubMed ID: 27138645
[TBL] [Abstract][Full Text] [Related]
11. The Traditional Chinese Medicine Compound, GRS, Alleviates Blood-Brain Barrier Dysfunction.
Zhang Y; Hu Y; Li M; Wang J; Guo G; Li F; Yu B; Kou J
Drug Des Devel Ther; 2020; 14():933-947. PubMed ID: 32184562
[TBL] [Abstract][Full Text] [Related]
12. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.
Wang L; Fan W; Cai P; Fan M; Zhu X; Dai Y; Sun C; Cheng Y; Zheng P; Zhao BQ
Ann Neurol; 2013 Feb; 73(2):189-98. PubMed ID: 23280993
[TBL] [Abstract][Full Text] [Related]
13. A broad-spectrum matrix metalloproteinase inhibitor prevents hemorrhagic complications induced by tissue plasminogen activator in mice.
Mishiro K; Ishiguro M; Suzuki Y; Tsuruma K; Shimazawa M; Hara H
Neuroscience; 2012 Mar; 205():39-48. PubMed ID: 22244977
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemia.
Li Q; Han X; Lan X; Hong X; Li Q; Gao Y; Luo T; Yang Q; Koehler RC; Zhai Y; Zhou J; Wang J
Neurobiol Dis; 2017 Dec; 108():173-182. PubMed ID: 28830843
[TBL] [Abstract][Full Text] [Related]
15. Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway.
Won S; Lee JH; Wali B; Stein DG; Sayeed I
J Cereb Blood Flow Metab; 2014 Jan; 34(1):72-80. PubMed ID: 24045404
[TBL] [Abstract][Full Text] [Related]
16. Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke.
Li M; Chen S; Shi X; Lyu C; Zhang Y; Tan M; Wang C; Zang N; Liu X; Hu Y; Shen J; Zhou L; Gu Y
J Neuroinflammation; 2018 Aug; 15(1):237. PubMed ID: 30139371
[TBL] [Abstract][Full Text] [Related]
17. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator.
Ishiguro M; Kawasaki K; Suzuki Y; Ishizuka F; Mishiro K; Egashira Y; Ikegaki I; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H
Neuroscience; 2012 Sep; 220():302-12. PubMed ID: 22710066
[TBL] [Abstract][Full Text] [Related]
18. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
[TBL] [Abstract][Full Text] [Related]
19. Post-treatment with yiqifumai injection and its main ingredients attenuates lipopolysaccharide-induced microvascular disturbance in mesentery and ileum.
Ayididaer A; Sun K; Pan CS; Yan L; Liu YY; Li DT; Fan JY; Han JY
Microcirculation; 2021 May; 28(4):e12680. PubMed ID: 33486837
[TBL] [Abstract][Full Text] [Related]
20. YiQiFuMai Powder Injection Attenuates Ischemia/Reperfusion-Induced Myocardial Apoptosis Through AMPK Activation.
Li F; Zheng X; Fan X; Zhai K; Tan Y; Kou J; Yu B
Rejuvenation Res; 2016 Dec; 19(6):495-508. PubMed ID: 27072567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
